Oral Solid Dosage Contract Manufacturing Market Projected to Reach USD 52.60 Billion by 2031 with Rising Adoption of Generic and Novel Therapeutics

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Tablets, Capsules, Powders, Granules, And Others (Lozenges, Pastilles)), Mechanism (Immediate-Release, Delayed-Release, And Controlled-Release), And End-User (Large-Size Companies, Medium- & Small-Size Companies)- Market Outlook And Industry Analysis 2031"

The Oral Solid Dosage Contract Manufacturing Market is estimated to reach over USD 52.60 billion by 2031, exhibiting a CAGR of 5.72% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1814

Solid dosage processing involves a range of technologies used to combine an Active Pharmaceutical Ingredient (API) with excipients to create a final dosage form, such as a tablet or capsule. Once the solid dosage has reached its final form, it must be properly packaged for distribution. Oral solid dosage forms are among the most commonly used pharmaceuticals for the treatment of various diseases and disorders. The market for these forms is expected to grow due to advancements in drug delivery technologies, including increased investments by Contract Development and Manufacturing Organizations (CDMOs) to enhance the development of oral solid dosages (OSD), targeted drug delivery systems, and sustained release formulations.

Additionally, there is a rising demand for innovative medications. While new technologies may emerge, it is unlikely that oral pharmaceutical products will be completely replaced. The development of new solid dosage formats and improvements in manufacturing efficiency are key drivers of growth in the solid dosage pharmaceutical manufacturing sector. Solid dosage processing services encompass various specialties, such as formulation and analytical development, technology transfer and scale-up, quality and regulatory support, commercial manufacturing, packaging, and warehousing.

List of Prominent Players in the Oral Solid Dosage Contract Manufacturing Market:
• Catalent Inc
• Lonza Group
• Piramal Pharma Solutions
• Aenova
• Jubilant
• Boehringer Ingelheim
• AbbVie Contract Manufacturing
• Patheon
• Recipharm
• Next Pharma AB
• Siegfried AG
• Corden Pharma

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics:
Drivers-
Numerous research institutions and organizations are actively involved in the drug discovery process, leading to the development of a significant volume of solid oral medications with improved efficacy, which are currently undergoing approval. The global rise in the prevalence of viral and chronic diseases has driven the demand for new therapeutics to address the needs of affected populations. Additionally, the widespread use of pharmaceutical medications among patients with diverse conditions has created a pressing need for large-scale manufacturing of innovative therapeutics.

Due to the increased demand for large-scale production, prominent pharmaceutical companies outsource contract manufacturing more frequently. As the demand for novel therapies grows, the need for oral solid dosage contract manufacturing will increase. large-size businesses were the end-user segment with the most significant revenue. The oral solid dosage manufacturing market is becoming increasingly characterized by cooperation, adaptability, and flexibility. The market is expanding due to rising demand for bilayer tablets and expenditures made by businesses to increase formulation and production of controlled-release tablets.

Challenges:
The oral solid dosage (OSD) contract manufacturing industry is highly competitive, as established service providers are expanding their service offerings, and some internal pharmaceutical operations are being restructured to provide contract manufacturing services. Additionally, the growing consolidation within the pharmaceutical industry has led to a reduction in the client base for contract manufacturers. In response to the intensifying market competition, OSD contract manufacturers are focusing on enhancing their product offerings by ensuring high-quality and consistent manufacturing processes while catering to the diverse requirements of sponsor companies.

Regional Trends:
The Asia Pacific region is expected to experience the fastest growth in the OSD contract manufacturing market, having already accounted for the largest market share in 2021. India and China, with their significantly lower production costs, are leading the OSD contract manufacturing market in the region. The manufacturing of generic drugs, driven by the increasing rate of patent expirations, serves as the second-largest revenue contributor in the Asia Pacific market. Furthermore, contract manufacturing organizations (CMOs) are continuing efforts to attain ISO certifications in areas such as energy efficiency, quality management, and environmental sustainability. While the number of warning letters has decreased in developed countries, there has been a rise in the Asia Pacific region, with most recalls attributed to violations of current Good Manufacturing Practice (cGMP) standards.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1814

Segmentation of Oral Solid Dosage Contract Manufacturing Market-
By Product Type Outlook-
• Tablets
• Capsules
• Powders
• Granules
• Others (Lozenges, Pastilles, etc.)
By Mechanism Outlook-
• Immediate Release
• Delayed Release
• Controlled Release
By End-user Outlook -
• Large-size Companies
• Medium- & Small-size Companies
• Others (Startups & Generic Pharmaceutical Companies)
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/oral-solid-dosage-contract-manufacturing-market/1814

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.